Novartis AG
NVS
NVS
NYSE
Health Technology
Pharmaceuticals: Major
151.12
USD-5.125
-3.28%
Closed: 10-23 20:00 (UTC+0)
151.50
USD+0.38
+0.25%
After Hours: 10-24 00:00 (UTC+0)
NVS Key Statistics
High
156.08
Open
156.08
Volume
4.35M
Low
149.17
Prev. Close
156.25
Trading Value
660.77M
52-Week High
170.46
Relative Volume
2.582
Amplitude (%)
4.42%
52-Week Low
121.57
Turnover Rate
0.21%
Market Cap
287.23B
P/E Ratio (TTM)
--
P/E Ratio (Annual)
21.674
P/B Ratio
4.1
P/S Ratio
5.97
Earnings Per Share (EPS)
--
Dividend (TTM)
3.407
Dividend Yield
--
Shares Outstanding
2.03B
Currency Unit
USD
NVS Price Performance
7 day
30 day
90 day
180 day
Year to date
1 Year
NVS Money Flow Distribution
NVS Daily Short Sale Volume
NVS Short Interest History
NVS Stock Snapshot
As of 2026-10-24, the Novartis AG (NVS) stock price today is 151.12. Based on this price, the company has a market capitalization of $287.23B, with a P/E ratio of --.
On 2026-10-24, NVS traded between 149.17 and 156.08. Today’s stock price is 1.31% above the daily low and 3.18% below the daily high, placing NVS in the lower range of its most recent trading range.
Trading volume currently stands at 4.35M, compared with an average daily volume of 1.68M. This suggests that trading activity is significantly above its usual level than usual.
Over the past year, Novartis AG shares have traded between 121.57 and 170.46. At today’s price, NVS is 24.31% above its 52-week low and 11.35% below its 52-week high.
NVS Related News
About NVS
Company Name
Novartis AG
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchanges
NYSE
Number of Employees
75,267
Lot Size
100
Official Website
Currency Unit
USD
Novartis AG (NVS) is a pharmaceutical company that develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
NVS FAQ
© 2026 CoinGlass, all rights reserved
